Search

everythinglearnresearchcommunity

for

Search:↓

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Geranium sibiricum may help manage diabetic complications by inhibiting a key enzyme.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Sarolaner effectively treats generalized demodicosis in dogs without side effects.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

New psoriasis treatments are effective but come with side effects and risks.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.